ASA
Pronunciation: AS-pir-in


What it isIrreversible COX-1 and COX-2 inhibitor; secondary cardiovascular prevention, acute coronary syndrome and stroke.
Why this oneIts irreversible platelet effect persists for each platelet's lifespan, distinguishing it from other NSAIDs.
What limits itGI bleeding limits use; primary prevention rarely justifies it. Avoid in viral illness in children; ibuprofen taken first blunts platelet effect.
Animated chart of estimated U.S. prescriptions per year, Antithrombotics (1914–2026). Aspirin enters in 1899 (estimated).
Principal riskGI bleeding, and Reye syndrome in children
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Temporary relief of minor aches and pains (delayed release — not for fast relief) | Adults & children ≥12 yr | 4 × 81 mg tablets q4h PRN | 4–8 × 81 mg tablets q4h while symptoms last | 48 × 81 mg tablets/24 h unless directed by a doctor |
Renal Undefined
Hepatic Undefined
81 mg delayed-release (safety coated) tablet; tablet counts apply only to this 81 mg product, not higher-strength aspirin tablets.
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 81 mg | tab | per unit | $0.01/ea | offered |
| 325 mg | tab | per unit | $0.02/ea | not offered |
| 500 mg | tab | per unit | not offered |
Open Aspirin in the interactive console ↗

Open Aspirin in the interactive console ↗